We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:MRNA
​
​
logo

Moderna (MRNA)

Nasdaq • MRNA • US60770K1079

258.38Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 20, 2026, ORTEX estimates 9.8% of free float is sold short, 2 days to cover, cost to borrow 0.48%.

Market Cap

103b USD | # 205 in US

Volume

21.33m shares | 3.53b USD

Shares Outstanding

399.24m

Free Float Shares

93.17% | 371.98m

DB:0QF|
XTRA:0QF|
LSE:0A45|
SWX:MRNA|
BOVESPA:M1RN34|
BIT:1MRNA|
BASE:MRNA|
WBAG:MRNA

News

MRNA key data

Moderna (Nasdaq: MRNA) has a market capitalization of $103.15B. Last close $258.38 (as of 2026-11-05); 52-week range $22.28 to $258.72. ORTEX data as of 2026-10-20: short interest is 9.81% of free float, 2 days to cover and the average cost to borrow is 0.48%.

Latest on MRNA

  • Sep 30, 2026Citigroup Sells Moderna at $203, Sees 61% Downside
  • Aug 4, 2026Moderna Heads Into Earnings With Bears Dug In and Options Turning Defensive
All MRNA news on ORTEX News
  • MRNA news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.